Unscrambling hepatitis C virus–host interactions (original) (raw)

• Hoofnagle, J. H. Course and outcome of hepatitis C. Hepatology 36, S21–S29 (2002).
  PubMed Google Scholar
• Alter, H. J. & Seeff, L. B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20, 17–35 (2000).
  Article CAS PubMed Google Scholar
• Alter, M. J. Epidemiology of hepatitis C. Eur. J. Gastroenterol. Hepatol. 8, 319–323 (1996).
  Article CAS PubMed Google Scholar
• Alter, M. J. Epidemiology of hepatitis C. Hepatology 26, 62S–65S (1997).
  Article CAS PubMed Google Scholar
• Alter, M. J. Hepatitis C virus infection in the United States. J. Hepatol. 31 (Suppl. 1), 88–91 (1999).
  Article PubMed Google Scholar
• Alter, M. J. Prevention of spread of hepatitis C. Hepatology 36, S93–S98 (2002).
  PubMed Google Scholar
• Spaulding, A., Greene, C., Davidson, K., Schneidermann, M. & Rich, J. Hepatitis C in state correctional facilities. Prev. Med. 28, 92–100 (1999).
  Article CAS PubMed Google Scholar
• Sulkowski, M. S., Mast, E. E., Seeff, L. B. & Thomas, D. L. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 30 (Suppl. 1), S77–S84 (2000).
  Article PubMed Google Scholar
• Choo, Q. L. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362 (1989).
  Article ADS CAS PubMed Google Scholar
• Sarnow, P. Viral internal ribosome entry site elements: novel ribosome–RNA complexes and roles in viral pathogenesis. J. Virol. 77, 2801–2806 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lohmann, V., Koch, J. O. & Bartenschlager, R. Processing pathways of the hepatitis C virus proteins. J. Hepatol. 24, 11–19 (1996).
  CAS PubMed Google Scholar
• Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D. & Pawlotsky, J. M. Structural biology of hepatitis C virus. Hepatology 39, 5–19 (2004).
  Article CAS PubMed Google Scholar
• Moradpour, D. et al. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol. 78, 13278–13284 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Samuel, C. E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778–809 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004).
  Article CAS Google Scholar
• Bartenschlager, R. Hepatitis C virus replicons: potential role for drug development. Nature Rev. Drug Discov. 1, 911–916 (2002).
  Article CAS Google Scholar
• Zhong, J. et al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA 102, 9294–9299 (2005).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623–626 (2005).
  Article ADS CAS PubMed Google Scholar
• Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Med. 11, 791–796 (2005).
  Article CAS PubMed Google Scholar
• Kato, T. et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64, 334–339 (2001).
  Article CAS PubMed Google Scholar
• Kato, T. et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808–1817 (2003).
  Article CAS PubMed Google Scholar
• Wieland, S. F. & Chisari, F. V. Stealth and cunning: hepatitis B and hepatitis C. J. Virol. 79, 9369–9380 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Rehermann, B. & Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev. Immunol. 5, 215–229 (2005).
  Article CAS Google Scholar
• Bigger, C. B. et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J. Virol. 78, 13779–13792 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Shoukry, N. H., Cawthon, A. G. & Walker, C. M. Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58, 391–424 (2004).
  Article CAS PubMed Google Scholar
• Neumann, A. U. et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 282, 103–107 (1998).
  Article ADS CAS PubMed Google Scholar
• Lanford, R. E. & Bigger, C. Advances in model systems for hepatitis C virus research. Virology 293, 1–9 (2002).
  Article CAS PubMed Google Scholar
• Foy, E. et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145–1148 (2003).
  Article ADS CAS PubMed Google Scholar
• Foy, E. et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl Acad. Sci. USA 102, 2986–2991 (2005).
  Article ADS CAS PubMed PubMed Central Google Scholar
• Mondelli, M. U. et al. Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Res. 52, 153–159 (2001).
  Article CAS PubMed Google Scholar
• Bowen, D. G. & Walker, C. M. Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. J. Exp. Med. 201, 1709–1714 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Meyer-Olson, D. et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200, 307–319 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• McHutchison, J. G. & Fried, M. W. Current therapy for hepatitis C: pegylated interferon and ribavirin. Clin. Liver Dis. 7, 149–161 (2003).
  Article PubMed Google Scholar
• Pawlotsky, J. M. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res. 59, 1–11 (2003).
  Article CAS PubMed Google Scholar
• Strader, D. B., Wright, T., Thomas, D. L. & Seeff, L. B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39, 1147–1171 (2004).
  Article PubMed Google Scholar
• Lamarre, D. et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426, 186–189 (2003).
  Article ADS CAS PubMed Google Scholar
• Nevens, F. et al. A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C. Hepatology 38, 1289–1296 (2003).
  Article CAS PubMed Google Scholar
• Shimizu, Y. K. et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68, 1494–1500 (1994).
  CAS PubMed PubMed Central Google Scholar
• Bassett, S. E. et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33, 1479–1487 (2001).
  Article CAS PubMed Google Scholar